FUTURES EXPO SERIES
INNOVAIVF
> This work has led to a patent submission PCT / AU2023 / 051132 .
> We have received awards , grants funding and student placements to develop an MVP .
Creating novel lab-on-a-chip and deep AI technology to personalise IVF treatments in real time
RESEARCH PROJECT
Infertility is a health challenge that impacts 12- 15 % of reproductiveaged couples worldwide . Despite escalating infertility rates , treatment advancements have remained constrained , with a static 30 % average live birth rate . Predominantly , embryo transfer disappointments stem from concealed metabolic aberrations tied to advanced reproductive age and suboptimal egg / embryo quality .
To date , embryo selection relies solely on visual morphological assessments . Consequently , the pursuit of dependable , non-invasive methods for gauging egg and embryo quality is a steadfast focal point within IVF . Enhanced embryo selection holds the potential to curtail the frequency of embryo transfers , translating into reduced emotional and financial burdens for patients seeking IVF remedies .
The research approach of InnovaIVF is to monitor metabolic activity levels through a straightforward , never-before-seen technology . This unique micro-optical configuration , with a mere $ AUD10 setup cost , carries the potential to catalyse seamless clinical integration .
44 •